Avista Healthcare Public Acquisition Corp.
Completed 2018-12-10- CIK 1661181
- AHPA
- Now ORGO
- IPO 2016-10-11
- $312M trust
- 671 filings
Successfully merged with Organogenesis Inc. • Now trading as ORGO
- IPO Size
- $310M
- raised at the IPO
- Trust
- $312M
- as of 2017-12-31
- Current Status
- Completed
- from its latest filing
- IPO Year
- 2016
- year it listed
Filings, by quarter
671 filings over 44 quarters; violet bars carry a milestone
- 15 Q4: 1 filing
- 16 Q1: 6 filings
- 16 Q2: 0 filings
- 16 Q3: 3 filings
- 16 Q4: 24 filings
- 17 Q1: 7 filings
- 17 Q2: 1 filing
- 17 Q3: 10 filings
- 17 Q4: 10 filings
- 18 Q1: 27 filings
- 18 Q2: 3 filings
- 18 Q3: 9 filings
- 18 Q4: 82 filings
- 19 Q1: 25 filings
- 19 Q2: 8 filings
- 19 Q3: 35 filings
- 19 Q4: 10 filings
- 20 Q1: 9 filings
- 20 Q2: 14 filings
- 20 Q3: 7 filings
- 20 Q4: 27 filings
- 21 Q1: 21 filings
- 21 Q2: 29 filings
- 21 Q3: 7 filings
- 21 Q4: 22 filings
- 22 Q1: 17 filings
- 22 Q2: 27 filings
- 22 Q3: 6 filings
- 22 Q4: 5 filings
- 23 Q1: 23 filings
- 23 Q2: 13 filings
- 23 Q3: 2 filings
- 23 Q4: 2 filings
- 24 Q1: 27 filings
- 24 Q2: 12 filings
- 24 Q3: 7 filings
- 24 Q4: 24 filings
- 25 Q1: 36 filings
- 25 Q2: 9 filings
- 25 Q3: 7 filings
- 25 Q4: 10 filings
- 26 Q1: 37 filings
- 26 Q2: 6 filings
- 26 Q3: 4 filings
- S-1 filed 15 Q4
- IPO 16 Q4
- Definitive agreement 18 Q3
- Completed 18 Q4
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
Avista Healthcare Public Acquisition Corp. is a blank-check company formed to effect a merger or similar business combination. Its initial focus is to acquire and operate a North American or European healthcare-related business.
Investment Focus
Healthcare
Geographic Focus
North America, Europe
Key Information
As the filings state it
- IPO Date
- 2016-10-11
- Total Redemptions
- $314M
- PIPE
- $46M
- Jurisdiction of Incorporation
- Delaware
- SIC
- 6770
- Completion Date
- 2018-12-10
- Merger Target
- Organogenesis Inc.
- SPAC Ticker
- AHPA
- Merged Ticker
- ORGO
Stock Performance
ORGOTrading symbol, and its price at each step since the first trade
| Point | Date | Price | Move |
|---|---|---|---|
| First Trade | 2017-01-05 | $9.85 | |
| At Merger | 2018-12-11 | $10.15 | +3% |
| 6 Months Post-Merger | 2019-06-12 | $7.30 | -28% |
| 1 Year Post-Merger | 2019-12-11 | $4.87 | -52% |
| 2 Years Post-Merger | 2020-12-10 | $4.86 | -52% |
| Current Price | 2026-10-09 | $1.29 | -87% |
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
The team is affiliated with Avista, a middle-market private equity firm; its founders and managers have decades of private-equity experience, and the management team and board have extensive healthcare investing, operating, sourcing and acquisition experience.